Reading Time: 4 minutesDue to the collaboration, hard work and partnerships with people affected by motor neurone disease (MND) who generously take part in research, new pieces of
Category: News
Reading Time: 2 minutesWe’ve stepped into the New Year! As part of the 30th International Symposium, the first ever Global Walk to D’Feet MND took place to raise
Reading Time: 5 minutesOn top of all the sharing of research and networking, the International Symposium is a time to celebrate the huge achievements of individuals/teams that contribute
Reading Time: 3 minutesTUDCA-ALS is a European Consortium (funded by the European Commission under the Horizon 2020 grant) involving top researchers from seven countries across Europe (see Figure
Reading Time: 3 minutesResearchers from University College London led by Dr Pietro Fratta and Dr John Thornton found that muscle imaging can help distinguish Amyotrophic Lateral Sclerosis (ALS)
Reading Time: 4 minutesRecently published results from the open-label Lighthouse trial investigating safety of the drug Triumeq in people with MND revealed the treatment was safe and ready
Reading Time: 5 minutesDespite the winter chill, there is a warm fuzzy feeling today with the news of a paper published in the journal ‘Brain’ by an MND
Reading Time: 7 minutesIn November 2018 the Home Office released a draft Guideline scope for Cannabis-based products for medicinal use in which they announced that specialist doctors (like
Reading Time: 5 minutesThere has recently been a flood of news stories on the outcomes of the Australian Phase 1 clinical trial investigating Copper ATSM (CuATSM) which is
Reading Time: 2 minutesOn Friday 5 May in America, the FDA, the organisation that approves drugs, announced that they’d granted a licence for the drug known as a